Review



ogd serum with tqhxd  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    MedChemExpress ogd serum with tqhxd
    Ogd Serum With Tqhxd, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 44 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ogd serum with tqhxd/product/MedChemExpress
    Average 94 stars, based on 44 article reviews
    ogd serum with tqhxd - by Bioz Stars, 2026-02
    94/100 stars

    Images



    Similar Products

    94
    MedChemExpress ogd serum with tqhxd
    Ogd Serum With Tqhxd, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ogd serum with tqhxd/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    ogd serum with tqhxd - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress gsk3827808a
    Gsk3827808a, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gsk3827808a/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    gsk3827808a - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress gsk2837808a
    Inhibiting glycolysis significantly reduces axonal regeneration in adult zebrafish retinal explants (A) Schematic overview of the experimental procedure. Retinas from naive Tg(Tru.gap43:eGFP) mil1 adult zebrafish were dissected, cut into explants, and cultured, as described previously. After four days, regenerated axons were quantified. (B) Six glycolysis inhibition conditions were tested: (1) 2-DG (2-deoxy-D-glucose, orange); (2) lactate (Lac, green); (3) Galactose (Gal, red); (4) an inhibitor mix (purple, 9 μM of 3PO, 9 μM of Malonyl-NAC, and 9 μM of <t>GSK2837808A</t> (GSK)); (5) 9 μM of 3PO alone (brown); (6) 9 μM of GSK alone (pink). (C) Representative images show that 2-DG caused the most severe axonal outgrowth reduction, with extremely few axons growing only short distances. Similarly, lactate treatment severely reduced axonal outgrowth, resulting in a limited number of regenerating axons. Galactose and inhibitor mix treatments also significantly impaired axonal outgrowth, but less severely. 3PO or GSK treatment induced a moderate reduction in regrowing axons compared to the vehicle. Scale bar 200 μm. (D) Cumulative distribution of axonal density profiles over distance from the explant. The 2-DG and lactate treatment severely impaired both the density and length of axons. Galactose or inhibitor mix administration caused a reduction in both axonal sprouting and elongation, but less severe than 2-DG and lactate. Treatments with 3PO or GSK induced slightly reduced sprouting, but strongly impaired elongation. See also . (E) Quantification of cumulative axonal density revealed a ∼90% reduction with 2-DG treatment, ∼85% with lactate, ∼60% with galactose or the inhibitor mix, and ∼40% with 3PO or GSK, compared to the vehicle control. Data of each condition were collected from N = 13–23 explants, derived from n = 26 fish across eight independent experiments, presented as median ±95% confidence interval (D) or median ±SEM and bootstrap 95% confidence interval versus vehicle-treated fish (E). One-way Kruskal-Wallis ANOVA (E). p values are reported within graphs. Abbreviations: DIV (day in vitro ), Veh (vehicle). Figure containing assets from BioRender.com .
    Gsk2837808a, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gsk2837808a/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    gsk2837808a - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress ldha inhibitor 84 gsk2837808a
    Inhibiting glycolysis significantly reduces axonal regeneration in adult zebrafish retinal explants (A) Schematic overview of the experimental procedure. Retinas from naive Tg(Tru.gap43:eGFP) mil1 adult zebrafish were dissected, cut into explants, and cultured, as described previously. After four days, regenerated axons were quantified. (B) Six glycolysis inhibition conditions were tested: (1) 2-DG (2-deoxy-D-glucose, orange); (2) lactate (Lac, green); (3) Galactose (Gal, red); (4) an inhibitor mix (purple, 9 μM of 3PO, 9 μM of Malonyl-NAC, and 9 μM of <t>GSK2837808A</t> (GSK)); (5) 9 μM of 3PO alone (brown); (6) 9 μM of GSK alone (pink). (C) Representative images show that 2-DG caused the most severe axonal outgrowth reduction, with extremely few axons growing only short distances. Similarly, lactate treatment severely reduced axonal outgrowth, resulting in a limited number of regenerating axons. Galactose and inhibitor mix treatments also significantly impaired axonal outgrowth, but less severely. 3PO or GSK treatment induced a moderate reduction in regrowing axons compared to the vehicle. Scale bar 200 μm. (D) Cumulative distribution of axonal density profiles over distance from the explant. The 2-DG and lactate treatment severely impaired both the density and length of axons. Galactose or inhibitor mix administration caused a reduction in both axonal sprouting and elongation, but less severe than 2-DG and lactate. Treatments with 3PO or GSK induced slightly reduced sprouting, but strongly impaired elongation. See also . (E) Quantification of cumulative axonal density revealed a ∼90% reduction with 2-DG treatment, ∼85% with lactate, ∼60% with galactose or the inhibitor mix, and ∼40% with 3PO or GSK, compared to the vehicle control. Data of each condition were collected from N = 13–23 explants, derived from n = 26 fish across eight independent experiments, presented as median ±95% confidence interval (D) or median ±SEM and bootstrap 95% confidence interval versus vehicle-treated fish (E). One-way Kruskal-Wallis ANOVA (E). p values are reported within graphs. Abbreviations: DIV (day in vitro ), Veh (vehicle). Figure containing assets from BioRender.com .
    Ldha Inhibitor 84 Gsk2837808a, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ldha inhibitor 84 gsk2837808a/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    ldha inhibitor 84 gsk2837808a - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress gsk 2837808a
    Inhibiting glycolysis significantly reduces axonal regeneration in adult zebrafish retinal explants (A) Schematic overview of the experimental procedure. Retinas from naive Tg(Tru.gap43:eGFP) mil1 adult zebrafish were dissected, cut into explants, and cultured, as described previously. After four days, regenerated axons were quantified. (B) Six glycolysis inhibition conditions were tested: (1) 2-DG (2-deoxy-D-glucose, orange); (2) lactate (Lac, green); (3) Galactose (Gal, red); (4) an inhibitor mix (purple, 9 μM of 3PO, 9 μM of Malonyl-NAC, and 9 μM of <t>GSK2837808A</t> (GSK)); (5) 9 μM of 3PO alone (brown); (6) 9 μM of GSK alone (pink). (C) Representative images show that 2-DG caused the most severe axonal outgrowth reduction, with extremely few axons growing only short distances. Similarly, lactate treatment severely reduced axonal outgrowth, resulting in a limited number of regenerating axons. Galactose and inhibitor mix treatments also significantly impaired axonal outgrowth, but less severely. 3PO or GSK treatment induced a moderate reduction in regrowing axons compared to the vehicle. Scale bar 200 μm. (D) Cumulative distribution of axonal density profiles over distance from the explant. The 2-DG and lactate treatment severely impaired both the density and length of axons. Galactose or inhibitor mix administration caused a reduction in both axonal sprouting and elongation, but less severe than 2-DG and lactate. Treatments with 3PO or GSK induced slightly reduced sprouting, but strongly impaired elongation. See also . (E) Quantification of cumulative axonal density revealed a ∼90% reduction with 2-DG treatment, ∼85% with lactate, ∼60% with galactose or the inhibitor mix, and ∼40% with 3PO or GSK, compared to the vehicle control. Data of each condition were collected from N = 13–23 explants, derived from n = 26 fish across eight independent experiments, presented as median ±95% confidence interval (D) or median ±SEM and bootstrap 95% confidence interval versus vehicle-treated fish (E). One-way Kruskal-Wallis ANOVA (E). p values are reported within graphs. Abbreviations: DIV (day in vitro ), Veh (vehicle). Figure containing assets from BioRender.com .
    Gsk 2837808a, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gsk 2837808a/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    gsk 2837808a - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress ldhi
    Inhibiting glycolysis significantly reduces axonal regeneration in adult zebrafish retinal explants (A) Schematic overview of the experimental procedure. Retinas from naive Tg(Tru.gap43:eGFP) mil1 adult zebrafish were dissected, cut into explants, and cultured, as described previously. After four days, regenerated axons were quantified. (B) Six glycolysis inhibition conditions were tested: (1) 2-DG (2-deoxy-D-glucose, orange); (2) lactate (Lac, green); (3) Galactose (Gal, red); (4) an inhibitor mix (purple, 9 μM of 3PO, 9 μM of Malonyl-NAC, and 9 μM of <t>GSK2837808A</t> (GSK)); (5) 9 μM of 3PO alone (brown); (6) 9 μM of GSK alone (pink). (C) Representative images show that 2-DG caused the most severe axonal outgrowth reduction, with extremely few axons growing only short distances. Similarly, lactate treatment severely reduced axonal outgrowth, resulting in a limited number of regenerating axons. Galactose and inhibitor mix treatments also significantly impaired axonal outgrowth, but less severely. 3PO or GSK treatment induced a moderate reduction in regrowing axons compared to the vehicle. Scale bar 200 μm. (D) Cumulative distribution of axonal density profiles over distance from the explant. The 2-DG and lactate treatment severely impaired both the density and length of axons. Galactose or inhibitor mix administration caused a reduction in both axonal sprouting and elongation, but less severe than 2-DG and lactate. Treatments with 3PO or GSK induced slightly reduced sprouting, but strongly impaired elongation. See also . (E) Quantification of cumulative axonal density revealed a ∼90% reduction with 2-DG treatment, ∼85% with lactate, ∼60% with galactose or the inhibitor mix, and ∼40% with 3PO or GSK, compared to the vehicle control. Data of each condition were collected from N = 13–23 explants, derived from n = 26 fish across eight independent experiments, presented as median ±95% confidence interval (D) or median ±SEM and bootstrap 95% confidence interval versus vehicle-treated fish (E). One-way Kruskal-Wallis ANOVA (E). p values are reported within graphs. Abbreviations: DIV (day in vitro ), Veh (vehicle). Figure containing assets from BioRender.com .
    Ldhi, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ldhi/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    ldhi - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    Image Search Results


    Inhibiting glycolysis significantly reduces axonal regeneration in adult zebrafish retinal explants (A) Schematic overview of the experimental procedure. Retinas from naive Tg(Tru.gap43:eGFP) mil1 adult zebrafish were dissected, cut into explants, and cultured, as described previously. After four days, regenerated axons were quantified. (B) Six glycolysis inhibition conditions were tested: (1) 2-DG (2-deoxy-D-glucose, orange); (2) lactate (Lac, green); (3) Galactose (Gal, red); (4) an inhibitor mix (purple, 9 μM of 3PO, 9 μM of Malonyl-NAC, and 9 μM of GSK2837808A (GSK)); (5) 9 μM of 3PO alone (brown); (6) 9 μM of GSK alone (pink). (C) Representative images show that 2-DG caused the most severe axonal outgrowth reduction, with extremely few axons growing only short distances. Similarly, lactate treatment severely reduced axonal outgrowth, resulting in a limited number of regenerating axons. Galactose and inhibitor mix treatments also significantly impaired axonal outgrowth, but less severely. 3PO or GSK treatment induced a moderate reduction in regrowing axons compared to the vehicle. Scale bar 200 μm. (D) Cumulative distribution of axonal density profiles over distance from the explant. The 2-DG and lactate treatment severely impaired both the density and length of axons. Galactose or inhibitor mix administration caused a reduction in both axonal sprouting and elongation, but less severe than 2-DG and lactate. Treatments with 3PO or GSK induced slightly reduced sprouting, but strongly impaired elongation. See also . (E) Quantification of cumulative axonal density revealed a ∼90% reduction with 2-DG treatment, ∼85% with lactate, ∼60% with galactose or the inhibitor mix, and ∼40% with 3PO or GSK, compared to the vehicle control. Data of each condition were collected from N = 13–23 explants, derived from n = 26 fish across eight independent experiments, presented as median ±95% confidence interval (D) or median ±SEM and bootstrap 95% confidence interval versus vehicle-treated fish (E). One-way Kruskal-Wallis ANOVA (E). p values are reported within graphs. Abbreviations: DIV (day in vitro ), Veh (vehicle). Figure containing assets from BioRender.com .

    Journal: iScience

    Article Title: Successful axonal regeneration is associated with intraneuronal metabolic reprogramming

    doi: 10.1016/j.isci.2025.113631

    Figure Lengend Snippet: Inhibiting glycolysis significantly reduces axonal regeneration in adult zebrafish retinal explants (A) Schematic overview of the experimental procedure. Retinas from naive Tg(Tru.gap43:eGFP) mil1 adult zebrafish were dissected, cut into explants, and cultured, as described previously. After four days, regenerated axons were quantified. (B) Six glycolysis inhibition conditions were tested: (1) 2-DG (2-deoxy-D-glucose, orange); (2) lactate (Lac, green); (3) Galactose (Gal, red); (4) an inhibitor mix (purple, 9 μM of 3PO, 9 μM of Malonyl-NAC, and 9 μM of GSK2837808A (GSK)); (5) 9 μM of 3PO alone (brown); (6) 9 μM of GSK alone (pink). (C) Representative images show that 2-DG caused the most severe axonal outgrowth reduction, with extremely few axons growing only short distances. Similarly, lactate treatment severely reduced axonal outgrowth, resulting in a limited number of regenerating axons. Galactose and inhibitor mix treatments also significantly impaired axonal outgrowth, but less severely. 3PO or GSK treatment induced a moderate reduction in regrowing axons compared to the vehicle. Scale bar 200 μm. (D) Cumulative distribution of axonal density profiles over distance from the explant. The 2-DG and lactate treatment severely impaired both the density and length of axons. Galactose or inhibitor mix administration caused a reduction in both axonal sprouting and elongation, but less severe than 2-DG and lactate. Treatments with 3PO or GSK induced slightly reduced sprouting, but strongly impaired elongation. See also . (E) Quantification of cumulative axonal density revealed a ∼90% reduction with 2-DG treatment, ∼85% with lactate, ∼60% with galactose or the inhibitor mix, and ∼40% with 3PO or GSK, compared to the vehicle control. Data of each condition were collected from N = 13–23 explants, derived from n = 26 fish across eight independent experiments, presented as median ±95% confidence interval (D) or median ±SEM and bootstrap 95% confidence interval versus vehicle-treated fish (E). One-way Kruskal-Wallis ANOVA (E). p values are reported within graphs. Abbreviations: DIV (day in vitro ), Veh (vehicle). Figure containing assets from BioRender.com .

    Article Snippet: GSK2837808A , MedChemExpress , Cat# HY-100681.

    Techniques: Cell Culture, Inhibition, Control, Derivative Assay, In Vitro